Lobby organisation
Valneva
Business / industry · Health & pharma · HQ: France · Transparency Register entry
As of 9 September 2026, Valneva appears in 14 declared MEP meetings (9 different MEPs), most often with Socialists & Democrats.
In their own words
“Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. Our vision is to live in a world in which no one dies or suffers from a vaccine-preventable disease. We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-,…”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 14 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2022–2026. Bar length is relative to its busiest year (4 in 2023).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 14 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 20 Mar 2026 | Wouter Beke | EU Biotech Act I |
| 18 Mar 2026 | Sirpa Pietikäinen | Vaccines for vector-borne diseases |
| 18 Mar 2026 | Vytenis Povilas Andriukaitis | Mosquito-borne diseases |
| 22 Apr 2025 | András Tivadar Kulja | Climate change-related disease outbreaks |
| 29 Jan 2025 | Vytenis Povilas Andriukaitis | Vaccines |
| 28 Jan 2025 | András Tivadar Kulja | Infectious diseases addressing unmet medical needs |
| 11 Dec 2024 | Günther Sidl | General Exchange of Views |
| 13 Nov 2024 | Tomislav Sokol | Health policy |
| 26 Oct 2023 | Nicolás González Casares | Vaccines |
| 27 Jun 2023 | Nicolás González Casares | Vaccines |
| 23 Mar 2023 | Kathleen van Brempt | Exchange of views on HERA - APA |
| 27 Jan 2023 | Valérie Hayer | Stratégie européenne de santé |
| 22 Nov 2022 | Günther Sidl | General Exchange of Views |
| 8 Nov 2022 | Kathleen van Brempt | Production of vaccines and the EU's longterm vaccine strategy |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.